share_log

Aethlon Medical Analyst Ratings

Aethlon Medical Analyst Ratings

Aethlon 医疗分析师评级
Benzinga ·  2023/10/24 13:55
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/24/2023 1542.86% HC Wainwright & Co. $90 → $23 Maintains Buy
11/15/2022 Maxim Group Downgrades Buy → Hold
06/25/2021 542.86% HC Wainwright & Co. $5 → $9 Maintains Buy
06/01/2021 257.14% HC Wainwright & Co. → $5 Initiates Coverage On → Buy
01/08/2021 328.57% Maxim Group → $6 Initiates Coverage On → Buy
日期 上行/下行 分析公司 目标价格变动 评级变动 之前/当前的评级
2023 年 10 月 24 日 1542.86% HC Wainwright & Co. 90 美元 → 23 美元 维护
11/15/2022 Maxim 集团 降级 买入 → 持有
06/25/2021 542.86% HC Wainwright & Co. 5 美元 → 9 美元 维护
06/01/2021 257.14% HC Wainwright & Co. → 5 美元 启动覆盖范围开启 → 购买
01/08/2021 328.57% Maxim 集团 → 6 美元 启动覆盖范围开启 → 购买

What is the target price for Aethlon Medical (AEMD)?

Aethlon Medical(AEMD)的目标价格是多少?

The latest price target for Aethlon Medical (NASDAQ: AEMD) was reported by HC Wainwright & Co. on October 24, 2023. The analyst firm set a price target for $23.00 expecting AEMD to rise to within 12 months (a possible 1542.86% upside). 2 analyst firms have reported ratings in the last year.

HC Wainwright & Co. 于2023年10月24日公布了艾思隆医疗(纳斯达克股票代码:AEMD)的最新目标股价。该分析公司将目标股价定为23.00美元,预计AEMD将在12个月内升至12个月内(可能上涨1542.86%)。去年有两家分析公司公布了评级。

What is the most recent analyst rating for Aethlon Medical (AEMD)?

分析师对Aethlon Medical(AEMD)的最新评级是多少?

The latest analyst rating for Aethlon Medical (NASDAQ: AEMD) was provided by HC Wainwright & Co., and Aethlon Medical maintained their buy rating.

HC Wainwright & Co. 对Aethlon Medical(纳斯达克股票代码:AEMD)的最新分析师评级由HC Wainwright & Co. 提供,Aethlon Medical维持买入评级。

When is the next analyst rating going to be posted or updated for Aethlon Medical (AEMD)?

Aethlon Medical(AEMD)的下一次分析师评级将在何时发布或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aethlon Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aethlon Medical was filed on October 24, 2023 so you should expect the next rating to be made available sometime around October 24, 2024.

分析师在进行了广泛的研究后得出了股票评级,其中包括浏览公开财务报表,与Aethlon Medical的高管和客户交谈,以及听取财报电话会议。大多数分析师每三个月做一次这样的评级,因此每家公司每年应该获得4次评级。Aethlon Medical的最新评级是在2023年10月24日公布的,因此您应该预计下一个评级将在2024年10月24日左右公布。

Is the Analyst Rating Aethlon Medical (AEMD) correct?

分析师对Aethlon Medical(AEMD)的评级是否正确?

While ratings are subjective and will change, the latest Aethlon Medical (AEMD) rating was a maintained with a price target of $90.00 to $23.00. The current price Aethlon Medical (AEMD) is trading at is $1.40, which is out of the analyst's predicted range.

尽管评级是主观的,并且会发生变化,但最新的Aethlon Medical(AEMD)评级维持不变,目标股价为90.00美元至23.00美元。Aethlon Medical(AEMD)目前的交易价格为1.40美元,超出了分析师的预期区间。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发